Share

October 12, 2021; 97 (15) ReviewOpen Access

COVID-19 and Vaccination in the Setting of Neurologic Disease

An Emerging Issue in Neurology

Elisabeth B. Marsh, Michael Kornberg, Kevin Kessler, Ihtsham Haq, Anup D. Patel, Avindra Nath, Becky Schierman, Lyell K. Jones, on behalf of the Quality Committee of the American Academy of Neurology
First published July 29, 2021, DOI: https://doi.org/10.1212/WNL.0000000000012578
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
13675

Share

Article Information

vol. 97 no. 15 720-728
DOI: 
https://doi.org/10.1212/WNL.0000000000012578
PubMed: 
34326180
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received May 5, 2021
  • Accepted in final form July 19, 2021
  • First Published July 29, 2021.

Article Versions

Copyright & Usage: 
Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Author Disclosures

    1. Elisabeth B. Marsh, MD,
    2. Michael Kornberg, MD, PhD,
    3. Kevin Kessler, MD,
    4. Ihtsham Haq, MD,
    5. Anup D. Patel, MD,
    6. Avindra Nath, MD,
    7. Becky Schierman, MPH,
    8. Lyell K. Jones Jr, MD;
    9. on behalf of the Quality Committee of the American Academy of Neurology
  1. Elisabeth B. Marsh, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. Philanthropic gift from the Iorizzo family

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Stroke, editorial board, 2018

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. National Institutes of Health

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. American Heart Association

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Michael Kornberg, MD, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. (1) Listed as inventor on a pending patent regarding the use of bryostatin-1 and related compounds as therapeutic agents in demyelinating and neuroinflammatory diseases

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Biogen Idec, (2) Janssen Pharmaceuticals (unrelated to vaccine development), (3) OptumRx

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. National Institute of Neurological Disorders and Stroke, K08NS104266, PI, 2019-2024

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) Doris Duke Charitable Foundation, 135904, (2) Conrad N. Hilton Foundation, 17316, (3) Race to Erase MS

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Kevin Kessler, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Ihtsham Haq, MD,
    5. Scientific Advisory Boards:

    1. Commercial Entities: 1)Two compensated scientific advisory boards for Boston Scientific DBS.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. I have salary support from 1) NINDS R01NS058949 (through 2025) 2) NINDS R01 MH121099-01 (through 2025) 3) NINDS 1U24NS107197-01 (completed 2020) 4) NIAA: P30 AG049638 (completed 2020)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Anup D. Patel, MD,
    6. Scientific Advisory Boards:

    1. Neurelis

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Greenwich Biosciences

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. Webinar Development for Medscape

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Stoke Encoded

    Research Support, Government Entities:

    1. R01NR017794-01A, NIH/NINR Site PI: 08/01/2018 – 06/30/2023 HRSA-16-055 QI consultant: 01/01/2017 – 12/31/2021 R21NR017633-01, NIH/NINR Site SI: 09/01/2018 – 08/01/2020

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Pediatric Epilepsy Research Foundation (PERF)

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Avindra Nath, MD,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Associate Editor, Journal of Neurovirology Editor, Practice Neurology Section Editor, Frontiers in Neurology

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH intramural funds

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Becky Schierman, MPH,
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. 1) American Academy of Neurology 2) Senior Director, Quality 3) 3 years

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Lyell K. Jones Jr, MD;
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Neurology: Clinical Practice, Editorial Board, 2016 to present

    Patents:

    1. NONE

    Publishing Royalties:

    1. Mayo Clinic Neurology Board Review book, Oxford University Press, 2015

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. Voluntary member of the AANI Board of Directors Voluntary member of the Mayo Clinic ACO Board of Directors Voluntary chair of the American Academy of Neurology Quality Committee Teaching honoraria from the American Academy of Neurology

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. on behalf of the Quality Committee of the American Academy of Neurology
    1. From The Johns Hopkins School of Medicine (E.B.M., M.K.), Baltimore, MD; The University of Virginia Medical Center (K.K.), Charlottesville; The University of Miami Miller School of Medicine (I.H.), FL; Nationwide Children's Hospital (A.D.P.), Columbus, OH; The National Institutes of Health (A.N.), Bethesda, MD; The American Academy of Neurology (B.S.), Minneapolis; and The Mayo Clinic (L.K.J.), Rochester, MN.
    1. Correspondence
      Dr. Marsh ebmarsh{at}jhmi.edu

    Article usage

    Article usage: July 2021 to October 2023

    AbstractFullPdfSource
    Jul 202111540191Highwire
    Aug 2021447202813Highwire
    Sep 2021181302737Highwire
    Oct 2021102134702750Highwire
    Nov 20212851151249Highwire
    Dec 2021382547822Highwire
    Jan 2022602941795Highwire
    Feb 2022482421484Highwire
    Mar 2022421798313Highwire
    Apr 202230921132Highwire
    May 202221831146Highwire
    Jun 202228529105Highwire
    Jul 20221063672Highwire
    Aug 202217580107Highwire
    Sep 2022856277Highwire
    Oct 202211654320Highwire
    Nov 202210401135Highwire
    Dec 20229231168Highwire
    Jan 20231036666Highwire
    Feb 20231427248Highwire
    Mar 20231232046Highwire
    Apr 2023823452Highwire
    May 2023624125Highwire
    Jun 2023516618Highwire
    Jul 20231011632Highwire
    Aug 2023810418Highwire
    Sep 2023723426Highwire
    Oct 2023617928Highwire

    Letters: Rapid online correspondence

    No comments have been published for this article.
    Comment

    REQUIREMENTS

    You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

    Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

    If you are responding to a comment that was written about an article you originally authored:
    You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
    and apply to letter.

    Submission specifications:

    • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
    • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
    • Submit only on articles published within 6 months of issue date.
    • Do not be redundant. Read any comments already posted on the article prior to submission.
    • Submitted comments are subject to editing and editor review prior to posting.

    More guidelines and information on Disputes & Debates

    Compose Comment

    More information about text formats

    Plain text

    • No HTML tags allowed.
    • Web page addresses and e-mail addresses turn into links automatically.
    • Lines and paragraphs break automatically.
    Author Information
    NOTE: The first author must also be the corresponding author of the comment.
    First or given name, e.g. 'Peter'.
    Your last, or family, name, e.g. 'MacMoody'.
    Your email address, e.g. [email protected]
    Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
    Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
    Publishing Agreement
    NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

    Vertical Tabs

    You May Also be Interested in

    Back to top
    Advertisement

    Related Articles

    • No related articles found.

    Alert Me